Browsing Category

64838 posts
Justin Yifu Lin: Chinese market crucial for high-tech firms in advanced countries

Justin Yifu Lin: Chinese market crucial for high-tech firms in advanced countries

BEIJING, March 4, 2024 /PRNewswire/ — A news report from chinadaily.com.cn: jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”  …
Quhuo's Homestay Business Branch Embarks on New Collaborative Ventures, Establishing 'Chengtu Rural Residence' Brand to Deepen Presence in Homestay Industry

Quhuo's Homestay Business Branch Embarks on New Collaborative Ventures, Establishing 'Chengtu Rural Residence' Brand to Deepen Presence in Homestay Industry

BEIJING, March 4, 2024 /PRNewswire/ — Quhuo Limited (NASDAQ: QH) ("Quhuo" or the "Company"),…
U Power Limited Introduces UOTTA, Revolutionizing EV Battery Swapping

U Power Limited Introduces UOTTA, Revolutionizing EV Battery Swapping

SHANGHAI, March 4, 2024 /PRNewswire/ — Youxu New Energy, a subsidiary of U…
MarketingPulse and eTailingPulse set to return on 13 March

MarketingPulse and eTailingPulse set to return on 13 March

Key players from across the world will discuss hot topics including AI, K-pop,…
Results from the Clinical Trial of Qilu Pharmaceutical's Novel Anticancer Agent Iparomlimab and Tuvonralimab (QL1706) Featured in Oral Presentation at the ESGO Annual Meeting

Results from the Clinical Trial of Qilu Pharmaceutical's Novel Anticancer Agent Iparomlimab and Tuvonralimab (QL1706) Featured in Oral Presentation at the ESGO Annual Meeting

JINAN, China, March 4, 2024 /PRNewswire/ — The European Society of Gynecological…
Vision beyond imagination: Hikvision showcases innovative display technologies and products at ISE 2024

Vision beyond imagination: Hikvision showcases innovative display technologies and products at ISE 2024

HANGZHOU, China, March 4, 2024 /PRNewswire/ — Hikvision unveiled a captivating array…
Caliway Announced Orphan Drug Designation Granted to CBL-514 for the Treatment of Dercum's Disease

Caliway Announced Orphan Drug Designation Granted to CBL-514 for the Treatment of Dercum's Disease

CBL-514 is the first and only drug to receive both Orphan Drug…
DMCC ANNOUNCES 25% ANNUAL GROWTH IN CHINESE MEMBER COMPANIES AS IT CONCLUDES FIRST 2024 CHINESE TRADE ROADSHOWS IN HONG KONG AND SHANGHAI

DMCC ANNOUNCES 25% ANNUAL GROWTH IN CHINESE MEMBER COMPANIES AS IT CONCLUDES FIRST 2024 CHINESE TRADE ROADSHOWS IN HONG KONG AND SHANGHAI

DMCC concludes Made For Trade Live roadshow in Hong Kong and twin…